The invention discloses a method for the treatment of diseases particularly those diseases characterized by diminished or aberrant cellular function including AIDS cancer and Alzheimer's Disease. The method comprises administering a therapeutically effective amount of rosuvastatin enantiomer compounds in their (3R 5R) (3S 5R) or (3S 5S) configurations or pharmaceutically acceptable salts thereof. Biologically-active rosuvastatin enantiomer compounds with (3R 5R) (3S 5R) and (3S 5S) stereochemistry are also disclosed.

暂无附图